Clinical Trial Update: Low Dose Morphine to Relieve Dyspnea in Acute Respiratory Failure (OPIDYS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating low-dose morphine to relieve dyspnea in acute respiratory failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Failure

Drugs mentioned

• Morphine (morphine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Respiratory Failure | Phase 2 | Status: COMPLETED